Clinical trials
Phase 2 Adenocarcinoma, Bronchiolo-Alveolar trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 4 |
| 2004 | 6 |
| 2005 | 12 |
| 2006 | 12 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2014 | 1 |
| 2017 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Terminated | 7 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 9 |
| National Cancer Institute (NCI) | 8 |
| Eastern Cooperative Oncology Group | 3 |
| Radiation Therapy Oncology Group | 3 |
| SWOG Cancer Research Network | 3 |
| Wake Forest University Health Sciences | 3 |
| Intergroupe Francophone de Cancerologie Thoracique | 2 |
| Swiss Cancer Institute | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
| Albert Einstein College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma, Bronchiolo-Alveolar | 59 |
| Carcinoma, Non-Small-Cell Lung | 53 |
| Adenocarcinoma of Lung | 47 |
| Lung Neoplasms | 45 |
| Adenocarcinoma | 2 |
| Adenocarcinoma, Mucinous | 1 |
| Adrenocortical Carcinoma | 1 |
| Anemia | 1 |
| Basal Cell Carcinoma | 1 |
| Bile Duct Neoplasms | 1 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.